Spagnol, G.; Marchetti, M.; Carollo, M.; Bigardi, S.; Tripepi, M.; Facchetti, E.; De Tommasi, O.; Vitagliano, A.; Cavallin, F.; Tozzi, R.;
et al. Clinical Utility and Diagnostic Accuracy of ROMA, RMI, ADNEX, HE4, and CA125 in the Prediction of Malignancy in Adnexal Masses. Cancers 2024, 16, 3790.
https://doi.org/10.3390/cancers16223790
AMA Style
Spagnol G, Marchetti M, Carollo M, Bigardi S, Tripepi M, Facchetti E, De Tommasi O, Vitagliano A, Cavallin F, Tozzi R,
et al. Clinical Utility and Diagnostic Accuracy of ROMA, RMI, ADNEX, HE4, and CA125 in the Prediction of Malignancy in Adnexal Masses. Cancers. 2024; 16(22):3790.
https://doi.org/10.3390/cancers16223790
Chicago/Turabian Style
Spagnol, Giulia, Matteo Marchetti, Massimo Carollo, Sofia Bigardi, Marta Tripepi, Emma Facchetti, Orazio De Tommasi, Amerigo Vitagliano, Francesco Cavallin, Roberto Tozzi,
and et al. 2024. "Clinical Utility and Diagnostic Accuracy of ROMA, RMI, ADNEX, HE4, and CA125 in the Prediction of Malignancy in Adnexal Masses" Cancers 16, no. 22: 3790.
https://doi.org/10.3390/cancers16223790
APA Style
Spagnol, G., Marchetti, M., Carollo, M., Bigardi, S., Tripepi, M., Facchetti, E., De Tommasi, O., Vitagliano, A., Cavallin, F., Tozzi, R., Saccardi, C., & Noventa, M.
(2024). Clinical Utility and Diagnostic Accuracy of ROMA, RMI, ADNEX, HE4, and CA125 in the Prediction of Malignancy in Adnexal Masses. Cancers, 16(22), 3790.
https://doi.org/10.3390/cancers16223790
